Controlled clinical trial of a novel hemostatic agent in cardiac surgery
Data up to Jan 2025
Total Citations Per Year
Abstract
References (19)
Bleeding complications associated with cardiopulmonary bypass
1990 • 602 citations
Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations
1989 • 262 citations
The hemostatic mechanism after open-heart surgery
1975 • 206 citations
Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V
1993 • 180 citations
Blood transfusion costs: a multicenter study
1991 • 174 citations
Comparativein VitroAnalysis of Topical Hemostatic Agents
1996 • 166 citations
Clinical Significance of Antibodies to Bovine and Human Thrombin and Factor V After Surgical Use of Bovine Thrombin
1992 • 132 citations
Evaluation of hemostatic agents in experimental splenic lacerations
1983 • 71 citations
Safety and efficacy of aprotinin under conditions of deep hypothermia and circulatory arrest
1995 • 58 citations
Shock, Transfusion, and Pneumonectomy
1990 • 48 citations
Modulation of an Acquired Coagulation Factor V Inhibitor with Intravenous Immune Globulin
1997 • 40 citations
Comparison of Two Topical Collagen-Based Hemostatic Sponges During Cardiothoracic Procedures
1999 • 39 citations
Aprotinin improves outcome of single-ventricle palliation
1996 • 37 citations
Pulmonary microvascular response to hemorrhagic shock, resuscitation, and recovery
1979 • 30 citations
Simultaneous Use of Microfibrillar Collagen Hemostat and Blood Saving Devices in a Canine Kidney Perfusion Model
1989 • 16 citations
Is aprotinin indicated for reoperative valvular surgery?
1997 • 7 citations
EFFECTS OF VARIOUS HEMOSTYPTIC DRUGS IN RATS
1972 • 6 citations
Randomized Clinical Trial of Fibrin Sealant in Cardiac Surgery Patients Undergoing Resternotomy or Reoperation: A Multicenter Study
1995 • 3 citations
Hemostatic agents. Adjuncts to control bleeding.
1991 • 3 citations